City Research Online

Life History Enlightened Therapies: Cell Cycle Mapping to Identify Molecular Targets to Prevent Hepatocellular Carcinoma

Bukkuri, A. ORCID: 0000-0002-3616-626X, McLaughlin, J., Duncan, A. W. & Stallaert, W. (2026). Life History Enlightened Therapies: Cell Cycle Mapping to Identify Molecular Targets to Prevent Hepatocellular Carcinoma. Evolution, Medicine, and Public Health, 14(1), pp. 1-13. doi: 10.1093/emph/eoag002

Abstract

Background and objectives

Life history enlightened therapies (LHETs) were originally developed in cancer to combat therapeutic resistance by targeting pathological cell state transitions that enable evolutionary rescue and adaptation to therapy. In this paper we expand the scope of LHETs to cancer prevention, namely metabolic dysfunction-associated steatohepatitis (MASH)-induced hepatocellular carcinoma (HCC) initiation. We focus on endocycling, a process wherein cells undergo whole-genome duplication via mitotic skipping, as a keystone life history transition that promotes HCC initiation.

Methodology

A key obstacle to LHET translation is the lack of systematic methods that capture cellular life histories and their molecular drivers. To address this gap, we introduce cell cycle mapping, a technique that integrates in situ multiplexed immunofluorescence imaging with manifold learning to visualize the life history of proliferating cells and proteins involved in transitions to pathological cell states.

Results

Mathematical modeling demonstrated how endocycling can create an environment that promotes HCC initiation and revealed the potential for endocycle-targeting therapies to prevent HCC. Using cell cycle mapping on human MASH liver tissues, we identified the molecular factors that drive pathological endocycling (Wee1, CDK2, and RAIDD), providing new therapeutic targets for pre-clinical investigation.

Conclusions and implications

This application illustrates how cell cycle mapping can uncover key proteins that drive disease-associated cell state transitions and broaden the scope of LHETs from therapy resistance to cancer prevention. More broadly, our study establishes a generalizable pipeline for inferring the life history of cells in diseased tissues and potential interventions for disease management.

Publication Type: Article
Additional Information: © The Author(s) 2026. Published by Oxford University Press on behalf of the Foundation for Evolution, Medicine, and Public Health. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Publisher Keywords: life history enlightened therapies, endocycling, cell state transitions, hepatocellular carcinoma, multiplexed immunofluorescence, cell cycle mapping
Subjects: Q Science > QA Mathematics
Q Science > QH Natural history > QH301 Biology
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Departments: School of Science & Technology
School of Science & Technology > Department of Mathematics
SWORD Depositor:
[thumbnail of emph_hcc.pdf]
Preview
Text - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Export

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Downloads

Downloads per month over past year

View more statistics

Actions (login required)

Admin Login Admin Login